In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks.

Items covered include:

• Review of the last podcast
• What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound
• We provide examples of Category 4 and Category 5 potent compounds
• Review upcoming events and happenings related to environmental, health and safety in the biotechnology, pharmaceutical, and medical device industry.

If you have any questions please contact Affygility Solutions at 303-884-3028 or visit the Affygility Solutions website.